| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.1 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |